Volume | 826 |
|
|||||
News | - | ||||||
Day High | 25.78 | Low High |
|||||
Day Low | 25.45 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Anika Therapeutics Inc | ANIK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.59 | 25.45 | 25.78 | 25.58 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
27 | 826 | $ 25.54 | $ 21,097 | - | 16.54 - 28.70 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:42:06 | 10 | $ 25.71 | USD |
Anika Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
374.51M | 14.64M | - | 166.66M | -82.67M | -5.65 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Anika Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANIK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 25.48 | 26.16 | 25.45 | 25.80 | 40,331 | -0.03 | -0.12% |
1 Month | 25.37 | 26.85 | 24.90 | 25.74 | 58,813 | 0.08 | 0.32% |
3 Months | 23.11 | 27.31 | 21.00 | 25.23 | 80,418 | 2.34 | 10.13% |
6 Months | 18.85 | 27.31 | 18.4355 | 23.35 | 84,568 | 6.60 | 35.01% |
1 Year | 26.64 | 28.70 | 16.54 | 21.43 | 115,601 | -1.19 | -4.47% |
3 Years | 41.62 | 48.37 | 16.54 | 27.54 | 97,825 | -16.17 | -38.85% |
5 Years | 32.85 | 75.715 | 16.54 | 35.48 | 120,222 | -7.40 | -22.53% |
Anika Therapeutics Description
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of revenue from the United States. |